分析性细胞病理学

For authors

Language editing and author services

我们已经与许多领先的作家服务提供商合作,为我们的作者提供了多种手稿准备和出版后服务的独家折扣。此折扣适用于各种语言编辑,翻译和研究通信服务。Learn more about author services.

Submission

Manuscripts should be submitted by one of the authors of the manuscript through the online manuscript tracking system. Only electronic PDF (.pdf) or Word (.doc, .docx, .rtf) files can be submitted through the MTS, and there is no page limit. Submissions by anyone other than one of the authors will not be accepted. The submitting author takes responsibility for the manuscript during submission and peer review. For technical help contacthelp@hindawi.com

Terms of submission

必须根据理解,必须提交手稿,即它们尚未在其他地方发表,并且仅由本期刊考虑。提交的作者负责确保该文章的出版物已获得所有其他合着者的批准。提交作者的责任也是确保本文获得所有必要的机构批准的责任。只有社论办公室的确认才能正式建立收据日期。除非另有说明,否则进一步的通信和证明将在发布前发送给作者。作者允许编辑手稿以供可读性编辑,这是提交的条件。有关公开手稿的所有询问均应介绍help@hindawi.com。All submissions are bound by Hindawi's terms of service.

Peer review

所有提交的文章都需要进行评估和同行评审,以确保编辑适当性和技术正确性。为了接受一篇文章的出版,分配的编辑将首先考虑手稿是否符合期刊范围内的最低编辑标准和适合。如果一篇文章在范围内,则编辑将在确认接受决定之前,理想地将至少有两个外部同伴审阅者(其身份仍然是作者匿名)来评估文章。拒绝的决定是由编辑决定的。

Our Research Integrity team will occasionally seek advice outside standard peer review, for example, on submissions with serious ethical, security, biosecurity, or societal implications. We may consult experts and the academic editor before deciding on appropriate actions, including but not limited to: recruiting reviewers with specific expertise, assessment by additional editors, and declining to further consider a submission.

Concurrent submissions

为了确保期刊作者的足够多样性,作者将仅限于在任何时间点进行三个手稿。如果作者已经在期刊上有三个手稿正在审查中,则他们需要等到这些手稿中的至少一个手稿完成,然后再提交另一个手稿进行考虑。此策略不适用于社论或其他未加入的手稿类型。

文章处理费用

The journal is Open Access. Article Processing Charges (APCs) allow the publisher to make articles immediately available online to anyone to read and reuse upon publication.

Preprints

Hindawi支持手稿在预印式服务器中的沉积,并不认为这是为了损害结果的新颖性。基于先前仅在预印式服务器,机构存储库或论文中公开的内容的文章将被考虑。应该引用预印本。

文章类型

The journal will consider the following article types:

研究文章

Research articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide a thorough analysis of the results of the project. Systematic reviews may be submitted as research articles.

临床研究

A clinical study presents the methodology and results of a study that was performed within a clinical setting. These studies include both clinical trials and retrospective analyses of a body of existing cases. In all cases, clinical studies should include a description of the patient group that was involved, along with a thorough explanation of the methodology used in the study and the results that were obtained.

When publishing clinical trials, Hindawi aims to comply with therecommendations国际医学杂志编辑委员会(ICMJE)的试验注册。因此,要求作者注册公共试验注册中手稿中提出的临床试验,并在摘要结束时包括试验注册号。在2005年7月1日之后发起的试验必须在开始招募之前前瞻性注册。对于2005年7月1日之前发起的试验,必须在提交之前进行登记。

评论

评论文章概述了特定主题领域已发表的文献。

Formatting

An optional research article manuscript template can be downloadedhere。We recommend that all manuscripts include line numbers and follow the structure below:

Title and Authorship Information

The following information should be included:
  • Manuscript title
  • Full author names
  • Full institutional mailing addresses
  • 电子邮件地址

从属关系。Hindawi Limited在机构隶属关系中的管辖权主张方面仍然保持中立。作者最终最终取决于作者,尽管印第安纳州可能会要求更改与分支机构中列出的国家,以确保已发表的输出(出于索引和发现原因)的一致性。

Abstract

手稿应包含摘要。摘要应独立,无引用,不应超过300个单词。

Introduction

This section should be succinct, with no subheadings.

Materials and Methods

方法部分应提供足够的细节,以便其他人能够复制研究。如果您有多种方法,请使用与相关标题的小节,例如不同模型,体外和体内研究,统计,材料和试剂等。

Hindawi journals have no space restriction on methods. Detailed descriptions of the methods (including protocols or project descriptions) and algorithms may also be uploaded as supplementary information or a previous publication that gives more details may be cited. If the method from a previous article is used then this article must be cited and discussed. If wording is reused from a published article then this must be noted, e.g. This study uses the method of Smith et al. and the methods description partly reproduces their wording [1].

If a method or tool is introduced in the study, including software, questionnaires, and scales, the license this is available under and any requirement for permission for use should be stated. If an existing method or tool is used in the research, the authors are responsible for checking the license and obtaining any necessary permission. If permission was required, a statement confirming permission was granted should be included in the Materials and Methods section.

发布协议。We encourage authors describing any methodology, in particular laboratory-based experiments in the life sciences but also computational and bioinformatics protocols, to upload details of their methods toprotocols.io。这是一个开放式访问网站,允许研究人员以结构化的方式记录其方法,获取doi以轻松引用该协议,与选定的同事合作,私下共享其协议以进行期刊同行评审,并选择公开可用。发布后,可以在其他文章中更新和引用该协议。

You canmake your protocol publicbefore publication of your article if you choose, which will not harm the peer-review process of your article and may allow you to get comments about your methods to adapt or improve them before you submit your article (see also the protocols.io常见问题页面)。

临床科学中的方案。We encourage authors of clinical trials and other clinical studies to upload the detailed plan of their study that was approved by the ethics committee as supplementary materials. If there is a published version of the protocol, this should also be cited in the methods section.

Results and Discussion

This section may be divided into subsections or may be combined.

主文字(仅查看)

This section may be divided into subsections or may be combined.

Conclusions

这应该清楚地解释本文的主要结论,强调其重要性和相关性。

数据可用性

This statement should describe how readers can access the data supporting the conclusions of the study and clearly outline the reasons why unavailable data cannot be released.

Conflicts of Interest

Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for coauthors declaring their interests.

Funding Statement

作者必须说明如何通过命名财务支持机构(全文编写),然后在方括号中使用相关赠款编号(如果适用)来资助其文章的研究和出版。例如:“这项工作得到了工程和物理科学研究委员会的支持[赠款XXXX,YYYY];国家科学基金会[赠款号ZZZZ];和Leverhulme Trust研究项目赠款”。

If the research did not receive specific funding, but was performed as part of the employment of the authors, please name this employer. If the funder was involved in the manuscript writing, editing, approval, or decision to publish, please declare this.

致谢

在参考文献之前,应在手稿的末尾包含所有确认(如果有)。任何对研究或手稿做出贡献但不是上市作者的人都应得到承认(允许他们的允许)。

References

Authors may submit their references in any style. If accepted, these will be reformatted in Chicago style by Hindawi. Authors are responsible for ensuring that the information in each reference is complete and accurate. All references should be numbered consecutively in the order of their first citation. Citations of references in the text should be identified using numbers in square brackets e.g., “as discussed by Smith [9]”; “as discussed elsewhere [9, 10]”. All references should be cited within the text and uncited references will be removed.

日期格式

Hindawi建议完全写作日期,以避免与不同的全非洲日期风格混淆。例如,2018年11月10日可能是2018年11月10日或2018年10月11日,具体取决于读者,因此应全额写出日期。例如,2018年9月1日的日期可以使用,而不是01/09/2018或09/01/2018。

Units of measurement

Units of measurement should be presented simply and concisely using the International System of Units (SI).

Preparation of figures

Upon submission of an article, authors should include all figures and tables in the PDF file of the manuscript. Figures and tables should not be submitted in separate files. If the article is accepted, authors will be asked to provide the source files of the figures. Each figure should be supplied in a separate electronic file. All figures should be cited in the manuscript in a consecutive order. Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel, etc.) or bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.). Bitmap images should be of 300 dpi resolution at least unless the resolution is intentionally set to a lower level for scientific reasons. If a bitmap image has labels, the image and labels should be embedded in separate layers.

地图。在已发布的地图中,Hindawi Limited在管辖权索赔方面仍然保持中立。出于一致性的原因,要求作者使用接受的标准地图作为地图图形图的基础,例如使用MAP PRESS的最新标准基础图。作者负责地图的责任是他们的责任,当使用作者不拥有或创建的地图时,也有责任提供任何版权或许可信息(例如Google Maps等)

Preparation of tables

应在文本中连续引用表。每个表都必须具有描述性标题,如果给出了数值测量,则该单元应包含在列标题中。不应使用垂直规则。

Supplementary materials

Supplementary materials are the additional parts to a manuscript, such as audio files, video clips, or datasets that might be of interest to readers. Authors can submit one file of supplementary material along with their manuscript through the Manuscript Tracking System. If there is more than one file, they can be uploaded as a .ZIP file.

A section titled “Supplementary Material” should be included before the references list with a concise description for each supplementary material file. Supplementary materials are not modified by our production team. Authors are responsible for providing the final supplementary materials files that will be published along with the article.

证明

纠正的证明必须在收到后的两到三天内退还给出版商。出版商将尽一切可能确保及时发布。

版权和权限

作者保留了手稿的版权,所有开放访问文章均根据创意共享归因许可证,只要适当地引用了原始作品,允许在任何媒介中不受限制地使用,分发和繁殖。

在本出版物中使用一般描述性名称,商标名称,商标等,即使没有明确识别,也不意味着这些名称不受相关法律和法规的保护。提交的作者负责确保手稿中包含的版权材料重复使用所需的任何许可。

While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

报告指南

Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximise transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of:

  • CONSORT对于随机对照试验
  • TREND用于非随机试验
  • PRISMA用于系统评价和荟萃分析
  • 关心for case reports
  • 频闪进行观察研究
  • Stregafor genetic association studies
  • SRQR进行定性研究
  • STARDfor diagnostic accuracy studies
  • 到达for animal experiments

利益冲突

当可以合理地认为研究外部问题以影响工作或评估的中立性或客观性时,就会发生利益冲突(COIS,也称为“竞争利益”)。有关更多信息,请参阅我们的出版道德政策。作者必须在“利益冲突”部分中宣布所有潜在利益(无论他们是否实际影响),这应该解释为什么利益可能是冲突。如果没有,作者应指出“作者宣布在本文的出版方面没有利益冲突”。提交作者负责宣布其利益的合着者。编辑和审阅者将考虑宣布的利益冲突,并将其包括在已发表的文章中。

Authors must declare current or recent funding (including for Article Processing Charges) and other payments, goods or services that might influence the work. All funding, whether a conflict or not, must be declared in the “Funding Statement”. The involvement of anyone other than the authors who 1) has an interest in the outcome of the work; 2) is affiliated to an organization with such an interest; or 3) was employed or paid by a funder, in the commissioning, conception, planning, design, conduct, or analysis of the work, the preparation or editing of the manuscript, or the decision to publish must be declared.
由于您的声明,您可能会要求您对手稿进行某些更改。这些请求不是指责不当的。编辑或审稿人正在帮助您保护工作免受潜在批评。
如果您对宣布潜在的冲突有任何疑问,请记住,如果稍后透露它(尤其是在出版之后),可能会导致更多的问题,而不仅仅是在提交时简单地宣布它。未申报的利益冲突可能会导致纠纷,或者在最严重的情况下撤回。

道德准则

In any studies on human or animal subjects, the following ethical guidelines must be observed. For any experiments on humans, all work must be conducted in accordance with the Declaration of Helsinki (1964). Manuscripts describing experimental work which carries a risk of harm to human subjects must include a statement that the experiment was conducted with the human subjects’ understanding and consent, as well as a statement that the responsible Ethical Committee has approved the experiments. In the case of any animal experiments, the authors must provide a full description of any anesthetic or surgical procedure used, as well as evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment.

上诉

如果作者认为拒绝的决定是基于:i)对手稿的技术方面的重大误解,或者ii)失败理解手稿所显示的科学进步。要求不充分理由提出第二意见的上诉将不考虑。要提起上诉,请通过电子邮件与日记联系,引用您的手稿号码。上诉只能从原始提交的作者中考虑。

分析性细胞病理学
期刊指标
Acceptance rate 25%
提交最终决定 83天
Acceptance to publication 41天
CiteScore 2.300
影响因子 2.052
Submit

我们致力于尽快分享与Covid-19的发现。我们将为公认的研究文章以及与Covid-19有关的案例报告和案例系列提供无限制的出版费用。审查文章被排除在此豁免政策之外。注册hereas a reviewer to help fast-track new submissions.